Vault-13

Aquilo Capital Management, LLC

SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-11-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$110.4m reported value -27.6% vs Q2 2023
12positions
98.1%in top 10
0 new 3 added 7 reduced 0 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 908,474 $24.4m22.12% 22.12% AddedShares held: Q4 2022 1.1m, Q1 2023 1.0m, Q2 2023 858.5k, Q3 2023 908.5k +50.0k +50,000 5.8%
2 BLUEPRINT MEDICINES CORP COM BPMC BPMC 379,090 $19.0m17.25% 17.25% ReducedShares held: Q4 2022 581.8k, Q1 2023 622.8k, Q2 2023 449.0k, Q3 2023 379.1k -69.9k -69,897 -15.6%
3 REGENXBIO INC COM RGNX RGNX 847,424 $13.9m12.64% 12.64% ReducedShares held: Q4 2022 897.7k, Q1 2023 831.0k, Q2 2023 870.1k, Q3 2023 847.4k -22.7k -22,690 -2.6%
4 SILENCE THERAPEUTICS PLC ADS SLN SLN 1,312,233 $12.9m11.68% 11.68% UnchangedShares held: Q4 2022 1.3m, Q1 2023 1.3m, Q2 2023 1.3m, Q3 2023 1.3m
5 KYMERA THERAPEUTICS INC COM KYMR KYMR 782,219 $10.9m9.85% 9.85% AddedShares held: Q4 2022 629.4k, Q1 2023 601.3k, Q2 2023 651.3k, Q3 2023 782.2k +130.9k +130,894 20.1%
6 MERUS N V COM MRUS MRUS 430,109 $10.1m9.19% 9.19% ReducedShares held: Q4 2022 1.4m, Q1 2023 1.2m, Q2 2023 775.1k, Q3 2023 430.1k -345.0k -345,000 -44.5%
7 ARVINAS INC COM ARVN ARVN 489,153 $9.6m8.71% 8.71% ReducedShares held: Q4 2022 673.9k, Q1 2023 628.9k, Q2 2023 623.9k, Q3 2023 489.2k -134.8k -134,788 -21.6%
8 C4 THERAPEUTICS INC COM STK CCCC CCCC 1,990,334 $3.7m3.35% 3.35% AddedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 760.7k, Q3 2023 2.0m +1.2m +1,229,677 161.7%
9 GENMAB A/S SPONSORED ADS GMAB GMAB 52,148 $1.8m1.67% 1.67% ReducedShares held: Q4 2022 242.8k, Q1 2023 242.8k, Q2 2023 174.6k, Q3 2023 52.1k -122.5k -122,500 -70.1%
10 ARGENX SE SPONSORED ADR ARGX ARGX 3,715 $1.8m1.66% 1.66% ReducedShares held: Q4 2022 24.0k, Q1 2023 24.0k, Q2 2023 16.3k, Q3 2023 3.7k -12.6k -12,600 -77.2%
11 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 88,875 $1.1m0.99% 0.99% ReducedShares held: Q4 2022 0, Q1 2023 0, Q2 2023 250.0k, Q3 2023 88.9k -161.1k -161,125 -64.5%
12 PIERIS PHARMACEUTICALS INC COM COM 3,303,190 $984.4k0.89% 0.89% UnchangedShares held: Q4 2022 4.6m, Q1 2023 4.6m, Q2 2023 3.3m, Q3 2023 3.3m